Transcription of ProductMonograph - Gilead Canada
{{id}} {{{paragraph}}}
Example: barber
ProductMonograph - Gilead Canada
ProductMonographINCLUDING PATIENT MEDICATION INFORMATIONPrVOSEVI (sofosbuvir/velpatasvir/voxilaprevir) tablets400 mg/100 mg/100 mgAntiviral AgentGilead Sciences City, CA 94404 USAG ilead Sciences Canada , , ON L5N Control No.: 202324 Date of Preparation: August 16, 2017 VOSEVI(sofosbuvir/velpatasvir/voxilaprev ir) tabletsProduct MonographPage 2 of 53 TABLE OF CONTENTSPART I:HEALTH PROFESSIONAL PRODUCT AND CLINICAL AND AND AND CLINICAL AND 29 SPECIAL HANDLING FORMS, COMPOSITION AND II:SCIENTIFIC INFORMATION ..31 PHARMACEUTICAL III: PATIENT MEDICATION (sofosbuvir/velpatasvir/voxilaprevir) tabletsProduct MonographPage 3 of 53 VOSEVI sofosbuvir/velpatasvir/voxilaprevirPART I:HEALTH PROFESSIONAL INFORMATIONSUMMARY PRODUCT INFORMATIONR oute of AdministrationDosage Form / StrengthClinically Relevant Nonmedicinal Ingredientso
ProductMonograph INCLUDING PATIENT MEDICATION INFORMATION PrVOSEVI™ (sofosbuvir/velpatasvir/voxilaprevir)tablets 400mg/100mg/100 mg …
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: